NCT06077877
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06077877
Title A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN | BRA

Facility Status City State Zip Country Details
GSK Investigational Site San Francisco California 94158 United States Details
GSK Investigational Site St Louis Missouri 63110 United States Details
GSK Investigational Site Dallas Texas 75230 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
GSK Investigational Site San Antonio Texas 78229 United States Details
GSK Investigational Site Fairfax Virginia 22031 United States Details
GSK Investigational Site Porto Alegre 90020-090 Brazil Details
GSK Investigational Site Vitória 29043-260 Brazil Details
GSK Investigational Site Edmonton Alberta T6G 1Z2 Canada Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Montreal Quebec H4A 3J1 Canada Details
GSK Investigational Site Panama City Panama Details
GSK Investigational Site Punta Pacifica Panama City Panama Panama Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field